Olivier Venier

USPTO Granted Patents = 13 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 82(Granted Patents)

Location History:

Saint Mande, FR (2005 - 2009)
Antony, FR (2011)
Rueil Malmaison, FR (2010 - 2013)
Paris, FR (2012 - 2018)

Company Filing History:

Years Active: 2005-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12441679 - Acrylamide-substituted indane compounds and therapeutic use thereof (2025-10-14),

2. 10077237 - Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases (2018-09-18),

3. 8536173 - Tetrahydroquinoxaline urea derivatives as modulators of 11-B-hydroxysteroid dehydrogenase type I (2013-09-17),

4. 8530657 - Substituted adamantanes and their therapeutic application (2013-09-10),

5. 8530477 - Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betaHSD1 (2013-09-10),

6. 8530473 - Tetrahydroquinoxaline urea derivatives as modulators of 11β-hydroxysteroid dehydrogenase type 1 (2013-09-10),

7. 8211892 - Tetrahydroquinoxaline urea derivatives (2012-07-03),

8. 7947834 - Substituted quinoxalines, their preparation and their therapeutical use as 11βHSD1 modulators (2011-05-24),

9. 7897773 - Urea derivatives of tropane, their preparation and their therapeutic application (2011-03-01),

10. 7812031 - Pyrimidine derivatives as orexin receptor antagonists (2010-10-12),

11. 7625929 - Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics (2009-12-01),

12. 7453010 - Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof (2008-11-18),

13. 6852736 - Phenoxypropanolamines, preparation and therapeutic use thereof (2005-02-08),

Title: Olivier Venier: Innovator in Therapeutic Compounds

Introduction

Olivier Venier is a prominent inventor based in Paris, France. He has made significant contributions to the field of therapeutic compounds, holding a total of 13 patents. His work focuses on innovative solutions for health-related issues, particularly in the treatment of diseases linked to AMP-activated protein kinase (AMPK).

Latest Patents

Venier's latest patents include groundbreaking inventions such as acrylamide-substituted indane compounds and their therapeutic applications. This invention relates to indane compounds of a specific formula and explores their preparation and therapeutic use. Another notable patent involves oxindole derivatives, which are also linked to the treatment of AMPK-related diseases. These compounds serve as modulators of AMPK activity and are particularly useful in addressing conditions like diabetes and obesity.

Career Highlights

Throughout his career, Olivier Venier has worked with notable companies, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in therapeutic treatments.

Collaborations

Venier has collaborated with esteemed colleagues such as Eric Nicolai and Claudie Namane. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic solutions.

Conclusion

Olivier Venier's contributions to the field of therapeutic compounds demonstrate his commitment to innovation and health improvement. His patents reflect a deep understanding of complex biological mechanisms and a dedication to finding effective treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.